Argenx Se ADR (ARGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARGX | REGN | ALNY | ||
| Company | Argenx Se ADR | Regeneron Pharmaceuticals | Alnylam Pharmaceuticals | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 845.94 | 790.00 | 332.24 | ||
| High | 852.48 | 790.00 | 339.61 | ||
| Low | 830.33 | 773.31 | 326.33 | ||
| Latest | 847.26 | 782.38 | 339.37 | ||
| Change | +1.91 | -9.78 | +6.69 | ||
| % Change | +0.23% | -1.23% | +2.01% | ||
| Volume | 339,700 | 505,000 | 1,152,900 | ||
| 20-Day Average Volume | 353,750 | 821,000 | 1,642,065 | ||
| Previous Close | 845.35 | 792.16 | 332.68 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 836.60 | 769.77 | 338.68 | ||
| 20-Day Raw Stochastic | 51.48% | 60.93% | 52.45% | ||
| 20-Day Relative Strength | 52.95 | 54.51 | 42.67 | ||
| Weighted Alpha | +36.03 | +24.85 | +15.77 | ||
| Today's Opinion | 48% Buy | 100% Buy | 72% Sell | ||
| Previous Opinion | 48% Buy | 100% Buy | 88% Sell | ||
| Last Month's Opinion | 24% Buy | 56% Buy | 40% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.52% since 02/11/26 | +0.44% since 02/11/26 | +5.30% since 02/11/26 | ||
| Low | 817.20 on 02/13/26 | 773.31 on 02/19/26 | 298.00 on 02/12/26 | ||
| High | 852.83 on 02/17/26 | 815.00 on 02/17/26 | 339.61 on 02/19/26 | ||
| 1-Month | |||||
| %Chg | +5.91% since 01/16/26 | +6.73% since 01/16/26 | -5.54% since 01/16/26 | ||
| Low | 781.07 on 01/20/26 | 718.38 on 01/20/26 | 298.00 on 02/12/26 | ||
| High | 881.89 on 01/27/26 | 815.00 on 02/17/26 | 376.87 on 01/22/26 | ||
| 3-Month | |||||
| %Chg | -7.36% since 11/19/25 | +11.33% since 11/19/25 | -26.35% since 11/19/25 | ||
| Low | 770.67 on 01/12/26 | 691.86 on 12/09/25 | 298.00 on 02/12/26 | ||
| High | 934.62 on 12/03/25 | 821.11 on 01/09/26 | 479.79 on 12/03/25 | ||
| 6-Month | |||||
| %Chg | +28.98% since 08/19/25 | +36.83% since 08/19/25 | -25.95% since 08/19/25 | ||
| Low | 651.89 on 08/20/25 | 541.00 on 10/13/25 | 298.00 on 02/12/26 | ||
| High | 934.62 on 12/03/25 | 821.11 on 01/09/26 | 495.55 on 10/20/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 52,312,784 | 83,747,152 | 44,121,020 | ||
| Shares Outstanding, K | 61,883 | 105,720 | 132,623 | ||
| Annual Sales | 2,252,040,000 | 14,342,900,000 | 3,713,940,000 | ||
| Annual Net Income | 833,040,000 | 4,504,900,000 | 313,750,000 | ||
| Last Quarter Sales | 1,151,340,000 | 3,884,300,000 | 1,097,030,000 | ||
| Last Quarter Net Income | 344,260,000 | 844,600,000 | 186,420,000 | ||
| 60-Month Beta | 0.37 | 0.40 | 0.35 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 5.18 on 10/30/25 | 11.44 on 01/30/26 | 0.82 on 02/12/26 | ||
| Latest Earnings Date | 02/26/26 | 05/05/26 | 05/07/26 | ||
| Most Recent Dividend | N/A | 0.940 on 02/20/26 | N/A | ||
| Next Ex-Dividends Date | N/A | 02/20/26 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 64.49 | 21.99 | 195.65 | ||